Beyond the Count: Why Particle Forensics Matters More Than Ever in Biologics Development
By Marissa Jones, PhD | March 2026 "We don't want to gamble with the success of our program, and we don't want to...
Webinars
Cutting Time, Cost, and Material for Viral Clearance Studies: A Proven Dual Virus Spike Approach
Summary KBI Biopharma and Texcell North America developed a proven dual virus spike approach for viral clearance...
Reducing CMC Risk Through TIME with KBI's Proven Analytical & Formulation Expertise
Speaker: Deanna Hunt, Senior Director of Business Development, Analytical and Formulation Sciences, KBI Biopharma...